Literature DB >> 3360028

Marchiafava-Bignami disease. A correlative computed tomography and morphological study.

P Heepe1, L Nemeth, F Brune, J W Grant, P Kleihues.   

Abstract

The subacute development of Marchiafava-Bignami disease (MBD) is reported in a 60-year-old patient from Southern Germany with a history of chronic alcoholism and severe malnutrition. Computed tomography scans showed progressive white matter destruction over a period of 8 months, ranging from diffuse hypodensities to well-delineated, strongly hypodense areas in the central hemispheric white matter of both frontal and parietal lobes and in the corpus callosum. Autopsy revealed an identical pattern of demyelinated, partially necrotic lesions in addition to small cystic necroses in the genu corporis callosi. The temporal evolution of MBD, criteria for early diagnosis and pathogenetic aspects are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3360028     DOI: 10.1007/bf00382370

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  23 in total

1.  Central demyelination of the corpus callosum (Marchiafava-Bignami disease) with report of a second case in Great Britain.

Authors:  R IRONSIDE; F D BOSANQUET; W H McMENEMEY
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

2.  Experimental cyanide encephalopathy.

Authors:  S LEVINE; W STYPULKOWSKI
Journal:  AMA Arch Pathol       Date:  1959-03

3.  Computerized tomography and MRI in Marchiafava-Bignami disease.

Authors:  S Bracard; D Claude; H Vespignani; M Almeras; M Carsin; H Lambert; L Picard
Journal:  J Neuroradiol       Date:  1986       Impact factor: 3.447

4.  Marchiafava-Bignami disease in a non-alcoholic Indian male.

Authors:  A S Leong
Journal:  Pathology       Date:  1979-04       Impact factor: 5.306

5.  [Electron microscopic findings concerning the pathogenesis of callosal lesions after experimental cyanide intoxication].

Authors:  A Hirner
Journal:  Acta Neuropathol       Date:  1969       Impact factor: 17.088

6.  Marchiafava-Bignami disease.

Authors:  M Dilmac; H Klein
Journal:  Acta Neuropathol Suppl       Date:  1981

7.  Experimental cyanide encephalopathy: gradients of susceptibility in the corpus callosum.

Authors:  S Levine
Journal:  J Neuropathol Exp Neurol       Date:  1967-04       Impact factor: 3.685

8.  A non-alcoholic Japanese patient with Wernicke's encephalopathy and Marchiafava-Bignami disease.

Authors:  K Kosaka; M Aoki; N Kawasaki; Y Adachi; I Konuma; R Iizuka
Journal:  Clin Neuropathol       Date:  1984 Nov-Dec       Impact factor: 1.368

9.  The influence of the ground substance on the extracellular water of normal and edematous human brain: focal edema and the demyelinating diseases, including multiple sclerosis.

Authors:  I Feigin; G N Budzilovich
Journal:  J Neuropathol Exp Neurol       Date:  1980-01       Impact factor: 3.685

10.  Marchiafava-Bignami disease. First case in germany.

Authors:  G F Walter
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-10-09
View more
  4 in total

1.  Marchiafava-Bignami disease. A case studied by structural and functional brain imaging.

Authors:  T Humbert; P De Guilhermier; C Maktouf; G Grasset; F M Lopez; P Chabrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

2.  Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures.

Authors:  R Baron; K Heuser; G Marioth
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis.

Authors:  T Polster; M Hoppe; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

Review 4.  Human alcohol-related neuropathology.

Authors:  Suzanne M de la Monte; Jillian J Kril
Journal:  Acta Neuropathol       Date:  2013-12-27       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.